Influenza virus surface antigens (inactivated).

Suspension for injection in pre-filled syringe.
Available forms may vary by country. Please refer to your local label.

Intramuscular or deep subcutaneous injection.

This medicine is used to help prevent influenza, particularly in individuals at increased risk of complications.
It is indicated for adults and children from 6 months of age, based on official vaccination recommendations.
Approved uses may differ by country. Always refer to the locally approved product information.

This vaccine is designed to help protect against influenza by stimulating the body’s immune system to produce antibodies. It contains inactivated components of influenza virus strains recommended for the relevant flu season. The vaccine is administered as a single dose in most cases, with a second dose recommended for certain children under 9 years of age who have not previously been vaccinated.

This medicine works by helping the body develop immunity to four specific strains of the influenza virus. It does this by introducing inactivated virus particles that trigger the production of protective antibodies. These antibodies help neutralize the virus if the person is exposed to it later.

Influenza vaccine

This page is intended for general informational purposes only and does not replace professional medical advice. Product availability, indications, and labelling may vary by country. Like all drugs, this medicine may cause side effects. Talk to your doctor if you experience any unusual symptoms. Always consult your healthcare provider and refer to the locally approved product information.